Fingerprint
Dive into the research topics of 'Outcomes following mepolizumab treatment discontinuation: Real-world experience from an open-label trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Outcomes following mepolizumab treatment discontinuation: Real-world experience from an open-label trial
Hector Ortega, Catherine Lemiere, Jean Pierre Llanos, Mark Forshag, Robert Price, Frank Albers, Steven Yancey, Mario Castro
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations